- Home
- XYF vs QSI Comparison
XYF vs QSI Comparison
Compare XYF & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XYF | QSI |
|---|---|---|
| Founded | 2014 | 2013 |
| Country | China | United States |
| Employees | N/A | 145 |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 186.4M | 194.8M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | XYF | QSI |
|---|---|---|
| Price | $4.89 | $1.14 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $1.00 |
| AVG Volume (30 Days) | 133.3K | ★ 6.2M |
| Earning Date | 05-18-2026 | 05-07-2026 |
| Dividend Yield | ★ 11.34% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $618.07 |
| P/E Ratio | $0.90 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.30 | $0.69 |
| 52 Week High | $20.36 | $3.10 |
Technical Indicators
Market Signals| Indicator | XYF | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 53.62 | 66.65 |
| Support Level | $4.86 | $0.88 |
| Resistance Level | $5.12 | $1.33 |
| Average True Range (ATR) | 0.31 | 0.08 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 67.33 | 86.26 |
Price Performance
Historical ComparisonAbout XYF X Financial each representing six
X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, and guarantee services provided.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.